Quinlan Paul T
Quinlan Paul T is a corporate insider (General Counsel) at TerraVia Holdings, Inc. (TVIA) filing SEC Form 4 transactions. 178 transactions across 3 companies, totaling $0 in purchases and $3,200,614 in sales. Source: SEC EDGAR.
Insider trading profile for Quinlan Paul T across three companies: (1) TerraVia Holdings (TVIA): 117 tx 2012-2017, 519K SELL (legacy, pre-acquisition/reorganization). (2) CymaBay Therapeutics (CBAY): 49 tx 2018-2024. M-code 5K batches at $2.94 exercise, S-code 5K sells at $13-$23; D-code distribution Mar 2024 totaling 720K+ shares distributed. (3) Oruka Therapeutics (ORKA): 2 tx. Jan 2025 A-code 162,500 shares at $12.50; Jun 2026 S-code 733 at $69.69. Key signal: ORKA A-code at $12.50 (Jan 2025) vs current $69.69 represents a 5.6x gain; the small S-code at $69.69 suggests partial profit-taking. CBAY D-code (distribution) of 720K+ shares in March 2024 is a one-time event (e.g., spin-off, merger distribution). Mixed -- biotech insider with consistent sell patterns at legacy names; ORKA shows large gain with early partial liquidation.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 42,000 | $12.50 | $525K | 120,500 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Exercise | 10,000 | $7.80 | $78K | 89,996 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 3,847 | $111.14 | $428K | 31,034 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 9,193 | $110.00 | $1.01M | 34,881 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 10,200 | $109.11 | $1.11M | 44,074 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 14,696 | $107.97 | $1.59M | 54,274 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 10,434 | $107.14 | $1.12M | 68,970 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 3,630 | $106.05 | $385K | 79,404 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Exercise | 42,000 | $12.50 | $525K | 83,034 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Exercise | 10,000 | $7.80 | $78K | 41,034 | 8/14/2026 Filed: 8/14/2026 | Filing → | |
| Sale | 733 | $69.69 | $51K | 31,034 | 6/15/2026 Filed: 6/15/2026 | Filing → | |
| Award | 162,500 | $12.50 | $2.03M | 162,500 | 1/22/2025 Filed: 1/24/2025 | Filing → | |
CymaBay Therapeutics, Inc. CBAY | Disposition | 105,625 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 215,000 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 107,000 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 22,167 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 233,176 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 28,438 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Disposition | 41,824 | - | - | 0 | 3/22/2024 Filed: 3/22/2024 | Filing → |
CymaBay Therapeutics, Inc. CBAY | Exercise | 41,824 | - | - | 8,872 | 3/13/2024 Filed: 3/15/2024 | Filing → |
Try asking...